Go Pro

Jin Medical International (ZJYL) Competitors

Jin Medical International logo
$2.86 +0.71 (+32.88%)
As of 03:57 PM Eastern
This is a fair market value price provided by Massive. Learn more.

ZJYL vs. ECOR, NYXH, COCH, MDAI, and SNWV

Should you buy Jin Medical International stock or one of its competitors? MarketBeat compares Jin Medical International with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Jin Medical International include electroCore (ECOR), Nyxoah (NYXH), Envoy Medical (COCH), Spectral AI (MDAI), and Sanuwave Health (SNWV). These companies are all part of the "healthcare equipment" industry.

How does Jin Medical International compare to electroCore?

electroCore (NASDAQ:ECOR) and Jin Medical International (NASDAQ:ZJYL) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, valuation, earnings, profitability, risk, analyst recommendations, dividends and media sentiment.

electroCore has a beta of 0.93, suggesting that its share price is 7% less volatile than the broader market. Comparatively, Jin Medical International has a beta of 7.33, suggesting that its share price is 633% more volatile than the broader market.

electroCore presently has a consensus target price of $18.00, indicating a potential upside of 106.28%. Given electroCore's stronger consensus rating and higher probable upside, analysts clearly believe electroCore is more favorable than Jin Medical International.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
electroCore
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Jin Medical International
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Jin Medical International has a net margin of 0.00% compared to electroCore's net margin of -39.96%. Jin Medical International's return on equity of 0.00% beat electroCore's return on equity.

Company Net Margins Return on Equity Return on Assets
electroCore-39.96% -1,956.38% -81.35%
Jin Medical International N/A N/A N/A

Jin Medical International has lower revenue, but higher earnings than electroCore.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
electroCore$32.03M2.46-$13.97M-$1.66N/A
Jin Medical International$20.69M0.94$1.19MN/AN/A

26.7% of electroCore shares are held by institutional investors. 7.8% of electroCore shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

In the previous week, electroCore had 2 more articles in the media than Jin Medical International. MarketBeat recorded 7 mentions for electroCore and 5 mentions for Jin Medical International. Jin Medical International's average media sentiment score of 0.44 beat electroCore's score of 0.19 indicating that Jin Medical International is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
electroCore
1 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Neutral
Jin Medical International
0 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

electroCore beats Jin Medical International on 8 of the 14 factors compared between the two stocks.

How does Jin Medical International compare to Nyxoah?

Jin Medical International (NASDAQ:ZJYL) and Nyxoah (NASDAQ:NYXH) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, dividends, risk, institutional ownership, media sentiment, valuation, profitability and analyst recommendations.

In the previous week, Nyxoah had 2 more articles in the media than Jin Medical International. MarketBeat recorded 7 mentions for Nyxoah and 5 mentions for Jin Medical International. Jin Medical International's average media sentiment score of 0.44 beat Nyxoah's score of -0.48 indicating that Jin Medical International is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Jin Medical International
0 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Nyxoah
1 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Neutral

Jin Medical International has higher revenue and earnings than Nyxoah.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Jin Medical International$20.69M0.94$1.19MN/AN/A
Nyxoah$11.33M5.37-$101.92M-$2.52N/A

Jin Medical International has a net margin of 0.00% compared to Nyxoah's net margin of -443.16%. Jin Medical International's return on equity of 0.00% beat Nyxoah's return on equity.

Company Net Margins Return on Equity Return on Assets
Jin Medical InternationalN/A N/A N/A
Nyxoah -443.16%-178.90%-81.83%

Jin Medical International has a beta of 7.33, indicating that its stock price is 633% more volatile than the broader market. Comparatively, Nyxoah has a beta of 1.62, indicating that its stock price is 62% more volatile than the broader market.

Nyxoah has a consensus target price of $5.26, suggesting a potential upside of 235.16%. Given Nyxoah's stronger consensus rating and higher probable upside, analysts clearly believe Nyxoah is more favorable than Jin Medical International.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Jin Medical International
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Nyxoah
1 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.25

Summary

Jin Medical International beats Nyxoah on 7 of the 12 factors compared between the two stocks.

How does Jin Medical International compare to Envoy Medical?

Jin Medical International (NASDAQ:ZJYL) and Envoy Medical (NASDAQ:COCH) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, profitability, analyst recommendations, risk, dividends, earnings and valuation.

Envoy Medical has a consensus price target of $2.25, suggesting a potential upside of 220.51%. Given Envoy Medical's stronger consensus rating and higher possible upside, analysts plainly believe Envoy Medical is more favorable than Jin Medical International.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Jin Medical International
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Envoy Medical
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

Jin Medical International has higher revenue and earnings than Envoy Medical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Jin Medical International$20.69M0.94$1.19MN/AN/A
Envoy Medical$240K224.87-$23.76M-$1.01N/A

In the previous week, Jin Medical International had 3 more articles in the media than Envoy Medical. MarketBeat recorded 5 mentions for Jin Medical International and 2 mentions for Envoy Medical. Jin Medical International's average media sentiment score of 0.44 beat Envoy Medical's score of 0.00 indicating that Jin Medical International is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Jin Medical International
0 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Envoy Medical
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Jin Medical International has a net margin of 0.00% compared to Envoy Medical's net margin of -9,875.64%.

Company Net Margins Return on Equity Return on Assets
Jin Medical InternationalN/A N/A N/A
Envoy Medical -9,875.64%N/A -177.92%

Jin Medical International has a beta of 7.33, meaning that its share price is 633% more volatile than the broader market. Comparatively, Envoy Medical has a beta of 1.9, meaning that its share price is 90% more volatile than the broader market.

8.6% of Envoy Medical shares are owned by institutional investors. 7.1% of Envoy Medical shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Summary

Jin Medical International beats Envoy Medical on 7 of the 13 factors compared between the two stocks.

How does Jin Medical International compare to Spectral AI?

Jin Medical International (NASDAQ:ZJYL) and Spectral AI (NASDAQ:MDAI) are both small-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, profitability, dividends, earnings, valuation, institutional ownership, media sentiment and risk.

Spectral AI has a consensus price target of $4.00, indicating a potential upside of 132.02%. Given Spectral AI's stronger consensus rating and higher probable upside, analysts clearly believe Spectral AI is more favorable than Jin Medical International.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Jin Medical International
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Spectral AI
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
2.67

In the previous week, Jin Medical International had 3 more articles in the media than Spectral AI. MarketBeat recorded 5 mentions for Jin Medical International and 2 mentions for Spectral AI. Jin Medical International's average media sentiment score of 0.44 beat Spectral AI's score of 0.00 indicating that Jin Medical International is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Jin Medical International
0 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Spectral AI
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Jin Medical International has a beta of 7.33, indicating that its stock price is 633% more volatile than the broader market. Comparatively, Spectral AI has a beta of 1.18, indicating that its stock price is 18% more volatile than the broader market.

Jin Medical International has a net margin of 0.00% compared to Spectral AI's net margin of -85.58%.

Company Net Margins Return on Equity Return on Assets
Jin Medical InternationalN/A N/A N/A
Spectral AI -85.58%N/A -72.97%

Jin Medical International has higher revenue and earnings than Spectral AI.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Jin Medical International$20.69M0.94$1.19MN/AN/A
Spectral AI$19.65M2.79-$7.57M-$0.53N/A

67.1% of Spectral AI shares are owned by institutional investors. 13.7% of Spectral AI shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

Jin Medical International and Spectral AI tied by winning 7 of the 14 factors compared between the two stocks.

How does Jin Medical International compare to Sanuwave Health?

Sanuwave Health (NASDAQ:SNWV) and Jin Medical International (NASDAQ:ZJYL) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, earnings, dividends, risk, profitability, media sentiment, analyst recommendations and institutional ownership.

Sanuwave Health presently has a consensus price target of $51.00, indicating a potential upside of 801.86%. Given Sanuwave Health's stronger consensus rating and higher probable upside, analysts clearly believe Sanuwave Health is more favorable than Jin Medical International.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Sanuwave Health
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
2.50
Jin Medical International
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Sanuwave Health has higher revenue and earnings than Jin Medical International.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sanuwave Health$44.05M1.10$11.81M$0.2423.56
Jin Medical International$20.69M0.94$1.19MN/AN/A

In the previous week, Sanuwave Health had 1 more articles in the media than Jin Medical International. MarketBeat recorded 6 mentions for Sanuwave Health and 5 mentions for Jin Medical International. Jin Medical International's average media sentiment score of 0.44 beat Sanuwave Health's score of -0.47 indicating that Jin Medical International is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Sanuwave Health
0 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Jin Medical International
0 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Sanuwave Health has a beta of 1.48, indicating that its stock price is 48% more volatile than the broader market. Comparatively, Jin Medical International has a beta of 7.33, indicating that its stock price is 633% more volatile than the broader market.

42.5% of Sanuwave Health shares are owned by institutional investors. 14.4% of Sanuwave Health shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Sanuwave Health has a net margin of 32.38% compared to Jin Medical International's net margin of 0.00%. Sanuwave Health's return on equity of 8,163.31% beat Jin Medical International's return on equity.

Company Net Margins Return on Equity Return on Assets
Sanuwave Health32.38% 8,163.31% 39.02%
Jin Medical International N/A N/A N/A

Summary

Sanuwave Health beats Jin Medical International on 13 of the 15 factors compared between the two stocks.

Get Jin Medical International News Delivered to You Automatically

Sign up to receive the latest news and ratings for ZJYL and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ZJYL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ZJYL vs. The Competition

MetricJin Medical InternationalHealthcare Equipment & Supplies IndustryHealthcare SectorNASDAQ Exchange
Market Cap$19.51M$5.79B$7.05B$12.94B
Dividend YieldN/A1.78%2.58%10.20%
P/E RatioN/A24.71269.7624.76
Price / Sales0.9467.65651.81108.50
Price / Cash11.7433.5528.8937.44
Price / Book0.766.2111.286.42
Net Income$1.19M$147.87M$3.45B$347.27M
7 Day Performance45.47%3.42%3.61%2.52%
1 Month Performance53.60%1.70%-0.53%-1.00%
1 Year Performance-78.29%6.22%77.55%23.29%

Jin Medical International Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ZJYL
Jin Medical International
0.7387 of 5 stars
$2.86
+32.9%
N/A-83.7%$19.51M$20.69MN/A245
ECOR
electroCore
2.7299 of 5 stars
$6.32
+1.4%
$18.00
+184.8%
+75.1%$57.01M$32.03MN/A50
NYXH
Nyxoah
2.8452 of 5 stars
$1.43
-1.7%
$5.96
+318.4%
-80.2%$55.23M$11.33MN/A110
COCH
Envoy Medical
2.3941 of 5 stars
$0.71
+3.6%
$2.25
+215.5%
-56.1%$54.83M$240KN/A34
MDAI
Spectral AI
1.8656 of 5 stars
$1.64
-0.6%
$4.00
+143.9%
-28.3%$52.19M$19.65MN/A83

Related Companies and Tools


This page (NASDAQ:ZJYL) was last updated on 8/10/2026 by MarketBeat.com Staff.
From Our Partners